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Solitary fibrous tumors (SFTs) are uncommon, and most are found in the pleura. Extrapleural SFTs are
rare and have been found in the lung, pericardium, mediastinum, soft tissue of any site, and upper
respiratory tract. SFTs of the central nervous system (CNS) are very rare. The biologic features are unknown
and remain poorly understood from a clinical standpoint. Most neurosurgeons do not believe that SFTs
can present as primary CNS neoplasms. Most SFTs are clinically benign and indolent, and recurrences
after surgical excision are scarce. Because malignant transformation or metastasis has been reported, all
SFTs should be treated as having malignant potential. Long-term follow-up is recommended. We report
two cases, so that surgeons may recognize that this is an entity different from other spindle-cell CNS tumors.
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First differentiated from mesothelioma by Klemperer and
Rabin in 1931 [1], solitary fibrous tumors (SFTs) usually
arise in the pleura [2–4]. They have also been found outside
the pleura, including in the soft tissues, lung, mediasti-
num, pericardium, upper respiratory tract, peritoneum [4],
tentorium, cerebellopontine angle, spinal dura, parasagit-
tal region, meninges [5], intraventricular region [6], liver
[7], external auditory meatus [8], falciform ligament [9],
and posterior cranial fossa [10]. SFTs within the central
nervous system (CNS), however, are rare. With increasing
awareness of primary extrapleural sites, reports of SFTs are
increasing. The exact incidence in the CNS is not clear, but
is reported to be low [2]. It is said that CNS SFTs account for
approximately 0.09% of all meningeal tumors [3]. There has
been little published on the clinical behavior of SFTs in the
CNS due to their rarity [11]. Most series primarily give
pathologic information rather than analyzing clinico-
pathologic correlates of tumor behavior [11]. The clinical
course, histogenesis, cytogenetics, prognosis, and treatment
protocol for CNS SFTs are still unknown [12]. We report two
peculiar cases of SFTs in the CNS, in a male and a female
patient.
CASE PRESENTATIONS
Case 1
A 58-year-old male patient presented with a progressive
intermittent unsteady gait, left hemiparesis, tinnitus, dizzi-
ness, and tremor in both hands. Grade II astrocytoma in
the right frontal lobe had been diagnosed 11 years earlier
and he had been followed regularly by the clinic. Magnetic
resonance imaging (MRI) disclosed a bulky, relatively well-
defined lesion about 8.3 cm in diameter in the right temporo-
occipital lobe that seemed to be extra-axial. This tumor
exhibited a low T1 weighted signal, a heterogeneous high
T2 weighted signal, multiple small intermediate-signal
nodules within the mass on the T1 weighted image (WI) and
T2WI, and punctuated low T2 weighted signal dots (Figure
1). Mild brain edema in the right parietal lobe was also seen.
The impression from radiologic evidence was that the mass
was a meningioma. Due to the possibility of recurrent astro-
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cytoma and persistent symptoms, the patient underwent
surgery about 4 months after presentation. Frozen sections
supported the diagnosis of meningioma. The patient has
received regular follow-up and has remained disease-free
for the 10 months since his surgery.
Case 2
A 35-year-old female sought treatment after 1 month of
intermittent headaches with associated bilateral blurred
vision and a decreased field of vision. She had no contribu-
tory medical history. Bilateral mydriasis and vessel engorge-
ment were seen in bilateral retinas. Computed tomography
(CT) revealed an amorphous and well-margined low-
attenuation lesion in the left cerebellopontine angle (Fig-
ure 2). Meningioma with compression of the brain stem
and fourth ventricle, and obstructive hydrocephalus were
suspected. The patient underwent surgery approximately
1 month later. Frozen section confirmed the diagnosis of
meningioma. The postoperative course was uneventful.
Characteristics
Microscopically, both cases showed similar features of
randomly alternating hyper- and hypocellular areas, inter-
spersed with a thick collagen background. Tumor cells
were vesicular and bland-appearing ovoid to spindle-
shaped. Their nuclei had fine chromatin but there was no
atypia, nucleoli, necrosis, or mitotic figures (Figure 3).
Scattered thin-walled small vessels were also seen. Case 2
had a focal hemorrhage. Repeated immunohistochemical
studies in both cases were strongly and diffusely positive
for CD34 and Bcl-2 and diffusely but weakly positive with
vimentin. There was no immunoreactivity with epithelial
membrane antigen (EMA), S-100 protein, cytokeratin (CK),
CD117, factor VIII, estrogen receptor, progesterone recep-
tor, synaptophysin, glial fibrillary acidic protein, HMB-45,
calretinin, desmin, smooth muscle actin (SMA), periodic
acid Schiff (PAS), and CD31. The collagen bundles stained
green with Masson’s trichrome stain. Interlacing reticulin
fibers were well demonstrated by reticulin stain (Figure 4).
The MIB-1 labeling index was approximately 2% in Case 1
and less than 1% in Case 2.
DISCUSSION
SFT is an uncommon and benign tumor [2]. Differential
diagnosis includes fibrous meningioma (FM) [2,3],
fibrosarcoma [3], meningeal sarcoma [5], meningeal myo-
fibroblastoma (MM) [5], schwannoma, neurofibroma [3,6],
hemangiopericytoma (HPC) [2,3,6], and gastrointestinal
stromal tumor (GIST) [13]. FM is strongly positive for EMA
and negative for CD34 [5]. Lack of expression of S-100
allows us to discriminate SFT from schwannoma and neuro-
fibroma, while no staining with SMA and desmin helps
to separate SFT from smooth muscle tumors and MM [3,5].
Sarcoma was unlikely because there was no anaplasia,
including nuclear pleomorphism, increased mitotic figures,
and necrosis [5]. CD34, a 100-kDa sialyated transmembrane
glycoprotein, is expressed in hematopoietic stem cells,
myeloid progenitor cells, the endothelium, endothelial pro-
genitor cells, and certain mesenchymal cells in the dermis
[2,3,14]. It is invariably and strongly expressed in SFT and
is considered a definitive marker of this entity [2,8,10,14–
18]. Intracranial SFTs are typically dura-based, CD34-
positive, mesenchymal neoplasms, and their histogenesis
Figure 1. Magnetic resonance image demonstrates a heterogeneous high
T2 weighted signal.
Figure 2. Computed tomography reveals an amorphous and well-margined
low-attenuation lesion located in the left cerebellopontine angle.
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remains elusive [6,19]. However, CD34 can be lost in high-
grade foci [20]. In both of our cases, the tumor was strongly
and diffusely positive for CD34, and SFT was the diagnosis.
Calretinin immunohistochemistry, when reported in
SFT-related literature, is negative [19]. SFTs are immuno-
reactive for Bcl-2 at 80–100% [17,21–23], and both our cases
were Bcl-2 positive. A high percentage of SFTs (75–100%)
also express CD99 [21,22]. CD117 staining is positive in
GIST and negative in SFTs [13,17]. Both of our cases were
CD117 negative and GIST was excluded. There is contro-
versy over the immunohistochemical expression of factor
VIII, with one positive report [21] and two negative reports
in the literature [24,25]. HMB-45, CD31, and PAS are rarely
discussed and are negative in literature reports [26–28],
which is in line with our cases. CK is negative in SFTs [24,
29]. Unlike SFT, meningeal HPC can metastasize and
has high rates of recurrence. HPC must, therefore, be dif-
ferentiated from benign spindle-cell tumors of the CNS,
including SFTs [29]. HPC is CD34 positive but with a patchy
and weak staining pattern, unlike the diffuse and strong
CD34 positivity of SFTs [29]. A common histologic pattern
of SFT is alternate hyper- and hypocellular areas with
bland-looking ovoid to spindle-shaped cells, packed by
reticulin fibers [2,5,6]. An HPC-like vascular pattern can be
found in SFTs [3], but was not seen in either of our cases.
From the histopathologic and immunohistochemical
Figure 3. Microscopic appearance. (A) The
hypercellular area exhibits a vague fascicular
growth pattern (hematoxylin & eosin, original
magnification × 40). (B) Some areas show
hypocellularity (hematoxylin & eosin, original
magnification × 100). (C) Interspersed collagen
background (hematoxylin & eosin, original
magnification × 200). (D) No malignant
cytologic features (hematoxylin & eosin,
original magnification × 400).
Figure 4. Immunohistochemical features.
(A) Epithelial membrane antigen staining is
negative. (B) Reticulin stain highlights
interspersed reticulin background. (C) S-100
staining is diffusely negative. (D) Diffuse and
strong CD34 immunopositivity. (Original
magnification × 400.)
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features (Table), our cases are both rare SFTs of the CNS.
Ultrastructurally, SFTs reveal fibroblastic or myo-
fibroblastic differentiation supporting a mesenchymal,
rather than meningothelial, origin [5,30,31]. They lack the
pinocytic vesicles and dense laminae characteristic of HPC
[10]. Hence, SFTs are different from HPCs.
CT shows an isodense irregular mass [10]. MRI is supe-
rior to CT because it gives better resolution of heteroge-
neous internal composition [32]. MRI does not reveal uni-
form or specific features, but shows diversity, such as two
components on T2WI [15], T1 weighted hypointensity
homogeneously enhanced with gadolinium [15], T1
isointensity with T2 hypointensity [32], and T1 weighted
isointensity with T2 weighted slightly high intensity and
mixed intensity [33]. In Case 1, MRI gave a low T1 weighted
signal and a heterogeneous high T2 weighted signal.
In Case 2, only CT was performed and revealed an amor-
phous and well-margined low-attenuation lesion, unlike
in previous reports [10]. Therefore, imaging might not be
able to provide a definite diagnosis.
SFTs are rare and generally benign [8,9]. Local invasion
or malignant transformation is uncommon and malignant
cases in the CNS are even more scarce [2,9]. Death due to an
SFT has only been reported once [31]. The criteria for ma-
lignancy include hypercellularity, more than four mitoses
per 10 high-power fields, and pleomorphism [23]. In our
cases, no anaplastic features were noted. The MIB-1 labeling
index seems to play a role in differentiation of benign and
malignant lesions, with a higher MIB-1 labeling index in
malignancies [34].
Hypoglycemia is rarely associated with SFTs, and it was
not seen in our cases [7]. In Case 1, the patient had a medical
history of astrocytoma in a different location. There is no
contributory medical history associated with SFTs in the
literature, except for one associated with schizophrenia for
20 years [18]. The biologic behavior is uncertain and the
cytogenetic background is poorly understood [35]. DNA
ploidy analysis in one report illustrated diploid content
[36]. Comparative genomic hybridization reveals some loss
in chromosomes 13 and 20q and some gains in 5q, 7, 8, 12,
and 18 [35]. In spite of the lack of anaplasia, comparative
genomic hybridization shows a loss in 20q, complex geno-
mic imbalances, and primitive features [35]. HPC does not
have these changes [37].
Use of chemotherapy or radiotherapy is not promising
[16]. The histogenesis and unpredictable behavior of SFTs
are a mystery [19,22]. Regardless of the benign appearance,
every case of SFT needs careful and long-term follow-up [4,
22,35].
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